PSP Projects reports good set of numbers for Q2FY19
PSP Projects reports good set of numbers for Q2FY19

PSP Projects reports good set of numbers for Q2FY19

Amir Shaikh Article rating: 5.0

PSP Projects reports its second-quarter number for FY19 on Monday during market hours. The company’s standalone revenue for the quarter came in at Rs. 209.9 crore, registering 50.4 per cent yoy increase. 


Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on November 5, 2018 opened gap down. BSE Sensex is trading at 34,881.76 down by 129.89 points and the Nifty is trading at 10,508.15, down by 44.85 points.

Uflex net sales grows 22 per cent YoY
Uflex net sales grows 22 per cent YoY

Uflex net sales grows 22 per cent YoY

Shohini Nath Article rating: 5.0

Uflex posted robust results as the net sales surged 22.49 per cent in Q2FY19 and stood at Rs. 1,072.82 crore as against Rs. 875.83 crore in the corresponding quarter of the previous year.

KEC International divests from Bikaner power transmission unit
KEC International divests from Bikaner power transmission unit

KEC International divests from Bikaner power transmission unit

Amir Shaikh Article rating: 5.0

KEC International signed a share purchase agreement with Adani Transmission on November 3, 2018 for sale of its entire stake in KEC Bikaner Sikar Transmission (KBSTPL) at an enterprise value of around Rs. 227.50 crore

Direct mutual funds investors gains with SEBIs decision on TER?
Direct mutual funds investors gains with SEBIs decision on TER?

Direct mutual funds investors gains with SEBIs decision on TER?

Henil Shah Article rating: 5.0

The Indian mutual fund industry regulator is very actively taking decisions that are beneficial to mutual fund investors. Let’s find out how the recent guidelines provided by the Securities & Exchange Board of India (SEBI) with respect to the Total Expense Ratio (TER) is beneficial for direct MF investors?

Strides Pharma surges post inspection
Strides Pharma surges post inspection

Strides Pharma surges post inspection

Sanket Dewarkar Article rating: 5.0

The facility (KRS Gardens) in Bangalore is the largest facility for the company and has the capability in several dosage formats including tablets, capsules (both hard gelatin and soft gelatin), ointments, creams and liquids. The facility supports several important current and future submissions for the US market.

RSS
First27942795279627972799280128022803Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR